Abbott Laboratories Statistics
Total Valuation
ETR:ABL has a market cap or net worth of EUR 198.09 billion. The enterprise value is 204.73 billion.
Market Cap | 198.09B |
Enterprise Value | 204.73B |
Important Dates
The last earnings date was Wednesday, April 16, 2025.
Earnings Date | Apr 16, 2025 |
Ex-Dividend Date | Apr 15, 2025 |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | -0.07% |
Shares Change (QoQ) | +0.06% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 1.72B |
Valuation Ratios
The trailing PE ratio is 15.92.
PE Ratio | 15.92 |
Forward PE | n/a |
PS Ratio | 5.06 |
PB Ratio | 4.47 |
P/TBV Ratio | 11.96 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | 16.45 |
EV / Sales | 5.50 |
EV / EBITDA | 20.47 |
EV / EBIT | 29.89 |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | 0.32 |
Debt / EBITDA | 1.34 |
Debt / FCF | n/a |
Interest Coverage | 14.23 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Invested Capital (ROIC) | 8.32% |
Return on Capital Employed (ROCE) | n/a |
Revenue Per Employee | 343,655 |
Profits Per Employee | 109,165 |
Employee Count | 114,000 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +13.35% in the last 52 weeks. The beta is 0.80, so ETR:ABL's price volatility has been lower than the market average.
Beta (5Y) | 0.80 |
52-Week Price Change | +13.35% |
50-Day Moving Average | 120.85 |
200-Day Moving Average | 110.26 |
Relative Strength Index (RSI) | 44.71 |
Average Volume (20 Days) | 606 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 2.94 |
Income Statement
In the last 12 months, ETR:ABL had revenue of EUR 39.18 billion and earned 12.44 billion in profits. Earnings per share was 7.13.
Revenue | 39.18B |
Gross Profit | 21.91B |
Operating Income | 7.20B |
Pretax Income | 6.80B |
Net Income | 12.44B |
EBITDA | 10.18B |
EBIT | 7.20B |
Earnings Per Share (EPS) | 7.13 |
Balance Sheet
The company has 7.37 billion in cash and 14.13 billion in debt, giving a net cash position of -6.76 billion.
Cash & Cash Equivalents | 7.37B |
Total Debt | 14.13B |
Net Cash | -6.76B |
Net Cash Per Share | n/a |
Equity (Book Value) | 44.32B |
Book Value Per Share | 25.47 |
Working Capital | n/a |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 55.92%, with operating and profit margins of 18.39% and 31.89%.
Gross Margin | 55.92% |
Operating Margin | 18.39% |
Pretax Margin | 17.37% |
Profit Margin | 31.89% |
EBITDA Margin | 25.98% |
EBIT Margin | 18.39% |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 2.10, which amounts to a dividend yield of 1.85%.
Dividend Per Share | 2.10 |
Dividend Yield | 1.85% |
Dividend Growth (YoY) | 7.50% |
Years of Dividend Growth | 6 |
Payout Ratio | n/a |
Buyback Yield | 0.07% |
Shareholder Yield | 1.92% |
Earnings Yield | 6.28% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |